Findings demonstrate limited hearing improvement with intratympanic steroids in persistent idiopathic sudden sensorineural hearing loss, suggesting tailored treatment approaches.
In patients with persistent ISSNHL after systemic corticosteroid therapy, intratympanic corticosteroid injections resulted in limited hearing improvement. Despite the low risks associated with this therapy, its routine use should be considered on a case-by-case evaluation.
No takes yet. Share an insight, caveat, or question.
Götting et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: